sun pharma glp 1 receives DCGI approval for Noveltreat, positioning itself strongly in India's fast-growing GLP-1 weight-management and diabetes therapy market ahead of patent expiry in 2026. #SunPharma #PharmaceuticalIndustry #GLP1 #Semaglutide and natural appetite control. Sun Pharma launches generic semaglutide
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6










02105-1/asset/8468e457-0c7f-4e4c-9b6d-2202dbefa9cb/main.assets/gr1_lrg.jpg)


















